Immediate Implant Placement With Immediate Professionalization in Aesthetic Area

Immediate Implant Placement With Immediate Professionalization in the Maxillary Esthetic Zone Using Mixture of Allograft and Xenograft vs Xenografts to Augment the Jumping Gap

Immediate implant placement with immediate professionalization in the maxillary esthetic zone using mixture of allograft and xenograft vs xenografts to augment the jumping gap

Study Overview

• Status: Unknown
• Conditions: Implant Site Reaction
• Intervention / Treatment: Other: immediate implant using mixed allograft and xenograft

Detailed Description

Implant placement in fresh extraction sockets in conjunction with appropriate guided bone regeneration has many benefits, which ultimately affect the total treatment plan. The immediate placement of implants provides significant advantages, including fewer surgical procedures, shorter treatment time, and improved esthetics. The goals of osseous replacement are maintenance of contour, elimination of dead space, and reduce postoperative infection, provide good support for dental implant and enhance bony and soft tissue healing. allograft bone has gold standard over other augment techniques including favorable bone quality and minimal bone resorption.

• Study Type: Interventional
• Enrollment (Anticipated): 2
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Kuwait
  • Q8
    • Kuwait, Q8, Kuwait, 00965
      • Mohammed

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years to 60 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Adult patients with badly broken teeth in upper esthetic zone indicated for extraction, presence of at least 4 mm of bone beyond the root apex to guarantee implant primary stability, implant placement within the alveoli confines.
• Both sexes.
• No intraoral soft and hard tissue pathology.
• No systemic condition that contraindicate implant placement.

Exclusion Criteria:

• Presence of fenestrations or dehiscence of the residual bony Walls after extraction.
• Heavy smokers more than 20 cigarettes per day .(24)
• Patients with systemic disease that may affect normal healing.
• Psychiatric problems
• Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: immediate implant placement with xenograft; Immediate implant placement with the use of xenograft as grafting material	Other: immediate implant using mixed allograft and xenograft; immediate implant using mixed allograft and xenograft in anterior area to fill jumping area
Experimental: immediate implant using mixed allograft and xenograft; Immediate implant placement with using mixture of allograft and xenograft material	Other: immediate implant using mixed allograft and xenograft; immediate implant using mixed allograft and xenograft in anterior area to fill jumping area

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Crestal bone loss	Will be measured using calliper with scale(1-10mm) for evaluation of crestal bone loss around implant which are the lower values represent a better outcome.	1 year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Patient satisfaction	Will be measured using a satisfaction table chart which divided in 4 paraments with scale from 1-4 include( pain-infection-radiography-successful implant ),the number represent (4 excellent-3 very good -2 good-1 bad)	1 year

Collaborators and Investigators

• Sponsor: Cairo University

Study record dates

Study Major Dates

• Study Start (Anticipated): January 1, 2019
• Primary Completion (Anticipated): January 1, 2019
• Study Completion (Anticipated): January 1, 2019

Study Registration Dates

• First Submitted: September 6, 2018
• First Submitted That Met QC Criteria: September 10, 2018
• First Posted (Actual): September 11, 2018

Study Record Updates

• Last Update Posted (Actual): September 12, 2018
• Last Update Submitted That Met QC Criteria: September 10, 2018
• Last Verified: September 1, 2018

More Information

Terms related to this study

• Other Study ID Numbers: 14422017463550

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No